Regenerative medicine, which aims at the process of replacing,
engineering or regenerating human cells, tissues or organs, so as
to restore or establish the normal function of a living organism,
is a prospective branch of medicine. Regenerative medicine is
popular worldwide in the recent decade, and has broad applications.
Many biological companies, research institutions and universities
are conducting research in this field. In the same time, a large
amount of patent applications in this field have been or are being
filed. In this article, we will discuss typical issues in
connection with patenting regenerative medicine in China, by
referring to reexamination and invalidation decisions.